Weed (BUDZ) Research & Development (2010 - 2012)

Weed (BUDZ) recorded quarterly Research & Development of $1359.0 in Q1 2012, up 70.09% quarter-over-quarter from $799.0 in Q4 2011, and down 49.16% on a YoY basis from $2673.0 in Q2 2011.

Weed (BUDZ) Research & Development (2010 - 2012) Analysis & Trends

Weed's Research & Development history runs 3 years deep, the most recent figure standing at $1359.0 for Q1 2012.

  • In Q1 2012, Research & Development fell 49.16% year-over-year to $1359.0; the TTM figure through Mar 2012 stood at $27333.0 (up 14.88% YoY), while the FY2011 annual figure was $28647.0, down 9.5% from the prior year.
  • Research & Development was $1359.0 for Q1 2012 at Weed, up from $799.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $16060.0 in Q3 2011 to a low of $799.0 in Q4 2011.
  • Historically, Research & Development has averaged $6390.8 across 3 years, with a median of $3560.0 in 2010.
  • Biggest YoY gain for Research & Development was 166.52% in 2011; the steepest drop was 78.41% in 2011.
  • A 3-year view of Research & Development shows it stood at $3700.0 in 2010, then sank by 78.41% to $799.0 in 2011, then surged by 70.09% to $1359.0 in 2012.
  • The last three Research & Development figures came in at $1359.0 (Q1 2012), $799.0 (Q4 2011), and $16060.0 (Q3 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Weed - - - -

Historic Data

Download Data
DateValue
Mar 31, 2012 1,359.00
Dec 31, 2011 799.00
Sep 30, 2011 16,060.00
Jun 30, 2011 9,115.00
Mar 31, 2011 2,673.00
Dec 31, 2010 3,700.00
Sep 30, 2010 14,000.00
Jun 30, 2010 3,420.00